RecruitingNCT06604039

A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices

A Prospective Clinical Registry Evaluating Safety and Performance of Teleflex Vascular Access Devices


Sponsor

Teleflex

Enrollment

2,500 participants

Start Date

Dec 8, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The general objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality Level 3 (or better) data on the performance, safety and clinical benefits of Teleflex's vascular access devices when used in a real-world setting


Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Central venous catheter for people with vascular access device. The study is currently recruiting participants at 3 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECentral venous catheter

Placement of a medical device to gain entry into the bloodstream, typically through a vein or artery, for the purpose of administering fluids, medications, blood products, or for hemodialysis


Locations(3)

Huntsville Hospital

Huntsville, Alabama, United States

Loma Linda University Health

Loma Linda, California, United States

Tufts Medical Center

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06604039


Related Trials